An analysis of global research shows that children with juvenile idiopathic arthritis, the form of the condition most often found in young people, have abnormally low blood levels of vitamin D.


While the focus of this particular study is vitamin D, we should not mistakenly assume that deficiencies of other micronutrients are rare in either adults or children. To the contrary, and as Dr. Rath’s groundbreaking Cellular Medicine concept explains, deficiencies of vitamins, minerals, amino acids, and other essential micronutrients are not only commonplace in the general population, they are the primary cause of today’s most common chronic diseases. Based on pioneering work conducted at the Dr. Rath Research Institute, this understanding has given rise to the revolutionary discovery that specific combinations of micronutrients can be used for the prevention and control of diseases.

To learn how Dr. Rath’s research has shown that specific micronutrient combinations can be helpful in painful joint conditions, read this article on our website.

Reaad the article on 



A new review has found that increasing the intake of omega-3 fatty acids during pregnancy reduces the risk of premature births.


Scientific studies show that proper micronutrient supplementation provides numerous health benefits both for the expectant mother and her developing child.

An important reason for this is that pregnancy increases the need for specific nutrients which may not be met through diet alone. A woman’s nutritional requrements change constantly during the different stages of pregnancy and while breastfeeding. In the absence of a sufficient supply of micronutrients, women are at risk of developing deficiencies that can adversely affect both their own health and that of the child they are carrying.

The actual process of giving birth also puts tremendous stress on a woman’s body, and a large amount of blood and nutrients are lost. This inevitably depletes her energy reserves. Ensuring proper nourishment during pregnancy, and also afterwards while nursing, is therefore critical. Micronutrients such as vitamin C, lysine, proline, folic acid, and the B group of vitamins, among others, are essential for a healthy baby and delivery, and for preventing complications during pregnancy.

Another important factor to consider is that the development of the various organs in the fetus starts and continues at different stages of pregnancy. Inadequate nourishment in any phase of pregnancy can therefore affect the baby’s organ systems, birth weight, and even survival. Crucially, the way the organs develop during pregnancy can also determine how their growth continues after the baby’s birth.

To learn more about the importance of micronutrients during pregnancy, read parts one and two of the special pregnancy feature article on our website.

Read the article at



Researchers at Curtin University in Australia have found that a garlic extract may help fight Alzheimer’s disease.


There is no doubt that both garlic extracts and garlic itself are highly beneficial to human health. Research suggests, for example, that certain compounds in garlic can help reduce the risk for cardiovascular diseases, as well as having anti-tumor and anti-microbial effects, and that they are also beneficial to patients with a high blood glucose concentration. Particularly impressively, even a simple homemade garlic extract has been scientifically shown to inhibit the growth of cancer cells.

Do you know how easy it is to grow your own supply of garlic at home? To learn how to do it, watch this short video on the Movement of Life website.

To learn how supplements of B vitamins and high levels of omega-3 have been shown to stop the development of Alzheimer’s disease, read this article on our website.

Readthe article at

A team of researchers from the Dr. Rath Research Institute in California has developed a cancer vaccine that is effective in reducing tumor growth. A peptide-based vaccine, it targets specific enzymes known as metalloproteinases (MMPs) that are necessary for any cancer to grow tumors, metastasize, and form blood vessels in tumors (angiogenesis). The Dr. Rath research team showed that test animals, vaccinated with peptides containing specific sequences from MMP-2 and MMP-9 and subsequently challenged with melanoma cancer cells, had an average reduction in tumor volume of about 76% compared to unvaccinated controls. Notably, some vaccinated animals did not develop any cancer at all.

The study was published this week in the online Journal of Cellular Medicine and Natural Health.1
Cancer remains the second largest epidemic, killing more than 7 million people each year worldwide. Decades of chemo- and radiotherapy and a myriad of recently introduced antibody therapies have done little to alter this. Now, this new therapeutic approach promises to change the situation.

Compared to monoclonal antibodies (Mabs) or biosimilar molecules recently developed to combat cancer, the anti MMP vaccine approach promises to be much more effective as well as affordable in the global fight against the disease. While Mabs/biosimilars are directed against one specific type of cancer, the anti-MMP vaccine targets all types of the disease at once. Moreover, while the Mabs/biosimilars generally require an injection once or twice each month, the anti-MMP vaccine would require one single vaccination with potential boosts only after several years. Additionally, while the annual costs of Mabs/biosimilar therapies average about US$ 100,000 and can reach US$ 700,000 per patient per year, the anti-MMP vaccination – if developed successfully – could be offered to the public by national or international health services at costs below US$ 10 per patient. Thus, this new approach promises to be the first therapy to be affordable for developing and threshold countries in the global fight against cancer. Most importantly, these vaccine candidates have the potential to prevent the disease in the first place, thereby opening the door to the elimination of cancer as a human epidemic.

To protect this valuable technology from being monopolized by certain investment industries and, thereby, prevent it from being made unaffordable to the majority of patients and nations, the Dr. Rath Research Institute has obtained patent protection2 for it in many countries. The Institute is looking for public research institutes, government research organizations, and other non-profit institutions to co-develop this promising technology with the goal to successfully treat, prevent, and eventually eliminate cancer.

Contact: Dr. Aleksandra Niedzwiecki, CEO, Dr. Rath Research Institute
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

1. Journal of Cellular Medicine and Natural Health
2. E.g. US Patents No.8003110 and 8067009

A new study has found that women undergoing chemotherapy treatment for cancer suffer more toxic side-effects than men. Presented at the European Society for Medical Oncology (ESMO) conference in Munich, Germany, the study analyzed data from four randomized controlled clinical trials conducted in the UK and Australasia. Compared to men, women were found to experience significantly higher rates of nausea and vomiting, with an increased likelihood of encountering severe toxicity symptoms. Far from acknowledging that chemotherapy indiscriminately kills cancer cells and healthy cells alike, however, the researchers simply concluded that further research is needed on the treatment’s impact and toxicity in women. 

The four trials analyzed in the study looked at chemotherapy combinations used in patients suffering from advanced esophageal and stomach cancer. The researchers looked at data on 1,654 patients, of whom 80 percent were male and 20 percent female. In addition to higher rates of nausea and vomiting, they found women were also more prone than men to developing diarrhea, mouth ulceration, and hair loss.

Cellular Medicine makes Victory Over Cancer possible

The real tragedy of the study reported at the ESMO conference is that despite recognizing the extreme toxicity of chemotherapy treatments, it fails to make any mention of the fact that a decisive breakthrough towards the natural prevention, control, and elimination of cancer in both men and women has already been made. Unknown to the majority of cancer patients worldwide, the initial discoveries towards reaching this scientific milestone were made more than two decades ago by Dr. Matthias Rath


By the end of 2001, in work led by Dr. Aleksandra Niedzwiecki, researchers at the Dr. Rath Research Institute had already obtained their first scientific confirmation that key steps in the development of cancer can be controlled naturally through the use of micronutrients. The researchers subsequently went public with this life-saving information by publishing a full-page announcement about it in USA Today, the newspaper with the world’s largest English language circulation. Since that time, the institute has published countless more studies demonstrating the effectiveness of micronutrients against cancer. Based on their results, it is now a scientific fact that micronutrient-based approaches can block all key mechanisms that make cancer a deadly disease.

As documented in the book Victory Over Cancer, natural therapies utilizing the synergistic power of the Cellular Medicine micronutrient approach have been shown to inhibit the multiplication of cancer cells and growth of tumors; the spread of cancer (metastasis); the formation of blood vessels in tumors (angiogenesis); as well as inducing the natural death of cancer cells (apoptosis). As a result of this work, the extensive research conducted by the Dr. Rath Research Institute’s scientists has definitively proven that a specific combination of micronutrients – including vitamin C, the amino acids lysine and proline, and an extract from green tea – work together synergistically and are effective in controlling over two dozen different types of cancer.

With separate research also now showing that, in some hospitals, within 30 days of starting treatment, chemotherapy kills up to 50 percent of patients who receive it, the blatantly false claims that the pharmaceutical and medical status quo has made about this toxic therapy as a treatment for cancer are no longer credible. The more patients begin to learn about this and realize that a cancer-free world is possible, the more they will inevitably turn their backs on toxic cancer treatments and choose to take their health into their own hands. Ultimately, therefore, while the attendees at the ESMO conference may not yet realize it, achieving a world without cancer depends just as much on patients themselves as it does on doctors and scientists.

Original Article: